Track topics on Twitter Track topics that are important to you
Lake Success, NY, September 23, 2016 --(PR.com)-- Voicebrook, Inc will exhibit VoiceOver®, the only speech recognition reporting solution created specifically for Pathology at the College of American Pathologists (CAP) annual meeting. The event will be held from September 25th through the 28th at the Wynn Encore Hotel in Las Vegas, Nevada. Representatives from Voicebrook will be at booth 601 from Sunday the 25th to Tuesday the 27th.
This year's CAP meeting will showcase collaborative relationships with health care societies. One such relationship is the 10-year collaboration between the American Society of Clinical Oncology and CAP to generate guidelines for numerous cancers such as breast, lung, and colorectal. The meeting will also feature almost 100 continuing medical education courses for the more than 1,500 attendees.
"We always look forward to the CAP annual meeting," says Joseph Desiderio, President of Voicebrook. "As the largest gathering of Pathologists, it gives us a tremendous opportunity to expose Pathologists to a solution that improves report turnaround time for better patient care."
VoiceOver's real-time report creation reduces turnaround time and allows Pathologists to create more accurate reports. There's no more wait for transcription. In addition to offering the most feature rich solution for gross and microscopic Pathology reporting, Voicebrook also offers the most customizable CAP eCC solution. The Structured Results Entry (SRE) application supports CAP's cancer reporting requirements and includes Agile checklist updates. With SRE, Pathologists receive CAP content updates from Voicebrook to achieve compliance with CAP cancer regulations without worry.
About Voicebrook: Voicebrook is the dominant provider of speech recognition-based reporting solutions for Pathology. Their solutions are used by more than 3500 users in 400 laboratories in the United States, Canada, and Australia. They empower the world of Pathology to save time, money, and lives. Voicebrook's VoiceOver solution is also the most flexible solution available. Users can create more accurate and standardized reports by using standard template sets or creating their own. These templates, including CAP eCC checklists, can be used to create reports in real-time when combined with VoiceOver's front-end speech recognition reporting capabilities.
VoiceOver also offers users the ability to choose digital dictation or deferred speech recognition workflows, allowing organizations to choose one reporting solution that fits the needs of all of their users. This combination of features coupled with Voicebrook's world class service offering promotes the highest amount of utilization rates where speech recognition-based reporting solutions are deployed. VoiceOver integrates directly with all major AP systems and expands upon core Dragon Medical functionality to ensure the highest levels of success with speech recognition in a laboratory environment, empowering Pathologists to save time, money, and lives.
VoiceOver utilizes Nuance’s Dragon® Medical 360 speech recognition technology and adds AP LIS specific “personalities” to maximize efficiency and improve reporting accuracy while decreasing report turnaround times. The solution was recently featured in the CAP Today article, “Hear me now? Another audition for speech recognition,” where multiple Voicebrook clients discussed how the software empowers them to save time, save money, and save lives.
(813) 344-3751 x3751
Contact via Email
Read the full story here: http://www.pr.com/press-release/688732
Press Release Distributed by PR.com
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
Track and monitor developments in breast cancer research and commercial development. Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...